Biopharma Insights - page 13

Navigating the Brain-Computer Interface Frontier: An Interview with ex-NASA Expert

In a detailed interview, Dr. Brian Jamieson, founder and CTO of Diagnostic Biochips (DBC), delves into the evolving landscape of brain-computer interfaces (BCIs), a domain where the fusion of neuroscience …

Continue ›››

It’s Been a Decade of AI in the Drug Discovery Race. What’s Next?

The year 2012 is often regarded as the beginning of the deep learning revolution. That year, Alexnet, the deep learning model proposed in the research paper Imagenet Classification with Deep …

Continue ›››

NVIDIA Introduces New Software Tools for Biopharma AI Applications

NVIDIA's CEO, Jensen Huang, recently outlined the company's expanded focus on software solutions designed to facilitate the adoption of artificial intelligence (AI) in the biopharmaceutical sector, beyond its well-established position …

Continue ›››

Notable Trends and Companies to Follow in Neuroscience

Historically, the approval rate for medicines treating central nervous system (CNS) disorders was low. By 2022, the success rate for CNS assets from phase 1 through to regulatory submission was only …

Continue ›››

11 Biopharma Trends to Watch in 2024

2023 has marked a remarkable year of technological advancements in drug discovery and biotechnology. Ironically, the elation from a kaleidoscope of technological and scientific advances is in stark contrast with …

Continue ›››

14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)

(Updated: 24.02.2024) Molecular mechanics (MM) is a traditional computational approach when it comes to modeling in synthetic organic chemistry, medicinal chemistry, and versatile aspects of drug design. However, MM methods …

Continue ›››

This Company Makes Quantum Computing Actually Useful

Quantum computing represents a monumental shift in the computational landscape, offering the potential to solve complex problems that are currently beyond the reach of classical computers. The principle behind quantum …

Continue ›››

This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery

Is There an "Innovator's Dilemma" in Biotech?

The term "Innovator's Dilemma" was coined by Clayton Christensen in 1997. The Innovator's Dilemma refers to a situation where successful, well-established companies face challenges in adopting and integrating new and …

Continue ›››

How Modern Biotechnology is Shaping Our Future

Covid 19 pandemic that we went through revealed the fragility of our world. Despite the undeniable technological advancements of the past century, the challenges we are facing are still numerous …

Continue ›››

10 Companies Applying AI for Biologics Discovery

When we hear “AI in drug discovery”, there is a high chance our imagination would draw a small molecule discovery in the first place. Indeed, as it was captured and …

Continue ›››

A Look at Five Promising Biotech IPOs in 2024

The year 2024 has ushered in a new wave of excitement in the biotech industry, with several promising companies making their debuts on the stock market.

Continue ›››